Safety, Pharmacokinetics, and Pharmacodynamics of Globalagliatin, a Glucokinase Activator, in Chinese Patients with Type 2 Diabetes Mellitus: A Randomized, Phase Ib, 28-day Ascending Dose Study.

Shuai ZhengFeng ShaoYu DingZhenzhen FuQi FuSijia DingLijun XieJuan ChenSufeng ZhouHongwen ZhangHongwen ZhouYang ChenCaixia SunJing ZhuXuqin ZhengYang Tao

Published in: Clinical drug investigation (2020)

Clinicaltrials.gov indentifier, NCT03414892.

Keyphrases

nuclear factor
pulmonary artery
coronary artery
inflammatory response
toll like receptor